- About SAM
- Human medicines
- Marketing authorisation
- Drug information
- Clinical trials
- European Pharmacopoeia
- Pharmacovigilance
- Classification of medicinal products
- Statistics
- Manufacture, distribution, pharmacy
- Travelling with medicinal products
- The import and export of goods that require a special authorization
- Sending of medicinal products
- Advertising
- Marketing authorisation
- Veterinary medicines
- Department of Biologicals
- Blood handling
- Procurement and handling of cells, tissues and organs
- Biovigilance
- Application of cells, tissues and organs licence
- List of licensed procurers and handlers of cells, tissues and organs (tissue establishments)
- Legislation for procurement and handling cells, tissues and organs
- Special authorisation for import and export and notification of import and export of cells, tissues and organs
- Advanced therapies medicinal products
- The import and export of goods that require a special authorisation
- Legislation
- Supervision
- Laboratory
Representatives of the Estonian State Agency of Medicines in main international working parties and scientific committees
25.03.2021
| Representative | |
|---|---|
| European Commission, Council | |
| Pharmaceutical Committee (Human) | Kristin Raudsepp |
| Pharmaceutical Committee (Vet) | Kristin Raudsepp |
| Standing Committee (Human) | Margit Plakso, Kaili Semm (alternate) |
| Standing Committee (Vet) | Kaili Semm |
| EC Drug Precursors Committee (DPC) + DPWG | Kristi Tõnisson |
| Council WG | SAM officials as national experts |
| Meetings of the Competent Authorities | 1. Organs - Ministry of Social Affairs 2. Tissues and Cells - Siim Suutre 3. Blood and Blood Components - Triin Suvi |
| EMA/CXMP | |
| EMA Management Board | Kristin Raudsepp |
| Formal (Scientific) Committees | |
| Committee for Human Medicinal Products (CHMP) | Alar Irs |
| Committee for Veterinary Medicinal Products (CVMP) | Toomas Tiirats |
| Committee for Orphan Medicinal Products (COMP) | Vallo Tillmann |
| Paediatric Committee (PDCO) | Irja Lutsar |
| Pharmacovigilance Risk Assessment Committee (PRAC) | Maia Uusküla |
| Committee for Advanced Therapies (CAT) | Toivo Maimets |
| Joint Working Groups | |
| Joint CHMP/CVMP Quality Working Party (QWP) | Laivi Saaremäel |
| GCP Inspectors Working Group | Katrin Tagel |
| GMDP Inspectors Working Group | Kaja Jantson |
| EMA/CXMP based Committee Working Parties and other sub-groups: | |
| Committee for Human Medicinal Products (CHMP) | |
| Safety Working Party (SWP) | Anti Kalda |
| Cardiovascular Working Party | Alar Irs |
| Heads of Medicines Agencies (HMA) | |
| Heads of Medicines Agencies (HMA) | Kristin Raudsepp |
| Co-ordination Group for Mutual Recognition and Decentralised Procedures- Human (CMD-h) | Margit Plakso |
| Co-ordination Group for Mutual Recognition and Decentralised Procedures- Veterinary (CMD-v) | Triinu Tereping |
| HMA working groups (joint) | |
| Working Group of Enforcement Officers (WGEO) | Kristi Tõnisson |
| Working Group of Quality Managers (WGQM) | Katrin Lambing |
| EMACOLEX | Kaili Semm |
| HMA working groups (human) | |
| Clinical Trials Facilitation Group | |
| OTHER | |
| PICs – The Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme | Kaja Jantson |
| European Council – European Pharmacopoeia meetings | Signe Leito |
| European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH) | Juhan Ruut |
| Committee of Experts on minimising the public health risks posed by counterfeiting of medical products and related crimes (CD-P-PH/CMED) | Katrin Kõiv/Riina Põder |
| EDQM, Committee of Experts on quality and safety standards in pharmaceutical practices and pharmaceutical care | Kaja Jantson |
| Commission on Narcotic Drugs (CND) | Kristi Tõnisson |
| Official Medicines Control Laboratories (OMCL) Network | Juhan Ruut |
State Agency of Medicines
